Article
DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.
Neuro-oncology - 1 Nov 2014
Marzese Diego M, Scolyer Richard A, Roqué Maria, Vargas-Roig Laura M, Huynh Jamie L, Wilmott James S, Murali Rajmohan, Buckland Michael E, Barkhoudarian Garni, Thompson John F, Morton Donald L, Kelly Daniel F, Hoon Dave S B
Abstract excerpt
BACKGROUND: The brain is a common target of metastases for melanoma patients. Little is known about the genetic and epigenetic alterations in melanoma brain metastases (MBMs). Unraveling these molecular alterations is a key step in understanding their aggressive nature and identifying novel therapeutic targets. METHODS: Genome-wide DNA methylation analyses of MBMs (n = 15) and normal brain tissues (n = 91) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
